Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer

Melissa A.L. Vyfhuis, Neha Bhooshan, Whitney M. Burrows, Michelle Turner, Mohan Suntharalingam, James Donahue, Elizabeth M. Nichols, Josephine Feliciano, Søren M. Bentzen, Shahed Badiyan, Shamus R. Carr, Joseph Friedberg, Charles B. Simone, Martin J. Edelman, Steven J. Feigenberg, Pranshu Mohindra

Research output: Contribution to journal › Article › peer-review

10 Scopus citations

Fingerprint

Dive into the research topics of 'Oncological outcomes from trimodality therapy receiving definitive doses of neoadjuvant chemoradiation (≥60 Gy) and factors influencing consideration for surgery in stage III non-small cell lung cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences